H_Review_Thyroid nodules Flashcards

1
Q

Thyroid nodules

A

5-14% change of malignancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Increased risk for malignancy:

A
  • <20 - >70
  • Men > Women
  • XRT
  • FMhx Thryoid cancer
  • ? elevated TSH
  • Nodules with FDG +ve PET with higher Standardized uptake value (SUV) is often
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Familial Factors

A

Medullary thyroid cancer 25%

  • MEN 2A or 2B
  • Familial medullary thyroid cancer FMTC
  • RET protooncogene mutation

Familial non medullary thyroid cancer

Syndromic

  • FAP and Gardner’s
    • Colorectal tumors/polyps + extracolonic tumors (osteomas of the skull,thyroid cancer, epidermoid cysts, fibromas)
  • PTEN - hmartoma tumor syndrome
    • most commonly lost tumor suppressors in human cancer
    • Cowden syndrome / breast, endometrial, thyroid, kidney and colorectalcancers, dermatologic features such as oral and skin papillomas, trichilemmomas,
  • Carneys complex
    • most commonly caused by mutations in the PRKAR1A gene
    • Myxomas may also occur outside the heart, usually in the skin and breast. Endocrine tumors may manifest as disorders such as Cushing syndrome. The most common endocrine gland manifestation is an ACTH-independent Cushing’s syndrome
  • Werner’s

Non Syndromic

  • Familial papillary ca
  • PTC associated with Renal neoplasis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Palpable nodule - what to do next?

A
  • TSH
    • High - Uptake scan / if cold nodule bx
    • Low - FNA with US
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

FNA recommendations

  • ATA 2009 -

High risk :

FMHx cancer

XRT at young age

Hx thyroid cancer

FDG +ve PET

MEN2/FMTC associated with RET

Calcitonin > 100

A
  • High risk - with/without US features > 5 MM
  • Abnormal Cervical LAD - All sizes
  • Microcalcification in nodules > 1 cm
  • Solid nodules & hypoechoic > 1 cm
  • Solid nodules & hyper/Isoechoic > 1.5 cm
  • Mixed cystic/solid w us features > 1.5-2 cm
  • Mixed cystic/solid wo us features > 2 cm
  • Spongiform nodule > 2cm
  • Purely cystic nodules FNA not recommended
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

High risk Sonographic features

A
  • Microcalcification / Punctate calcifications (denoting dots or tiny holes)
  • Hypoechoic
  • Increased nodular vascularity
  • Infiltrative margins
  • Taller than wide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Benign findings

Comet-tail

A

Seen in cystic nodules with coloid cristals

=

-

.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Cancer / Prevelance / Nodule

A
  • Prevalence of thyroid cancer per patient is independent of number of the nodules
  • Prevalence of thyroid cancer per nodule decreases as the number nodules increases
  • Each nodule needs to be evaluated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Cytopathology what it means

  • Non diagnostic
  • Benign
  • Atypia of undetermined significance
  • Suspicious of follicular neoplasm
  • Suspicious for Malignancy (pap)
  • Malignant
A
  • Non diagnostic 1-4% cancer
    • Repeat FNA
  • Benign 0-3% cancer
    • Clinical follow up
  • Atypia of undetermined significance / 5-15% cancer
    • Repeat FNA
  • Suspicious of follicular neoplasm / 15-30% cancer
    • Surgical lobectomy (Hurthle Cell hyperplasia)
  • Suspicious for Malignancy (pap) / 60-75% cancer
    • Total/lobar resection
  • Malignant / 97-99% cancer
    • Total thyroidectomy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Benign Nodule Cytology

A

Not overlapping

large clump of cells

evenly dispursed

Dark nuclie

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Benign nodule cytology II

A

tissue paper like colloid

amcrophages as well (hemosecrine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Malignant PCT

A

look at the nucleus inclusion bodies (clear areas)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Malignant pct

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

MTC - medullary thyroid cancer

A

cells are very spidle like , staining for calcitonis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Follicular neoplasm

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Follicular neoplasm

A

Normal cytoplasmic normal

Microfollicular pattern

However they arranged in small groups

17
Q

Hurthle Cell neoplasm

A

subtype of follicular neoplasm

  • granular cytoplasm / monomorphic
  • may have lyphocytic thyroitditis (hashimatos)
18
Q

Hurthle Cell neoplasm

A
19
Q

Molecular markers on Cytology

A

Papillary thyroid cancer

  • BRAF, RET/PTC, RAS

Follicular Carcinomas

  • RAS, PAX8/PPARy

Cytology and + ve Mutation = cancer probability 89%

20
Q

Autonomous nodules

A

Will have suppressed TSH

Could be solitary vs MNG

/

21
Q

Follow up for benign nodules

A
  • no real consensus on definition of growth

ATA 2009

Follow up with US in 6-18 months after initial FNA

if Stable in size follow up interval can be increased to 3-5 yrs

If > 50% increase in nodule volume

or > 20% increase in diameter in at least 2 dimensions repeat FNA